WT1 and cancer: To further examine the induction of TAA-specific memory T cells by ZSTK474 in cancer settings, we used PBMCs from three gastric cancer patients who exhibited humoral immune responses against WT-1, NY-ESO-1, MAGE-A3 or MAGE-A4 that were expressed by their own tumors.